Zobrazeno 1 - 10
of 1 461
pro vyhledávání: '"S, Macaluso"'
Autor:
Anna Viola, Marco Muscianisi, Fabio S Macaluso, Marco Ventimiglia, Maria Cappello, Antonino C Privitera, Antonio Magnano, Dario Pluchino, Giovanni Magrì, Concetta Ferracane, Filippo Mocciaro, Serena Garufi, Enrica Giuffrida, Giuseppe Costantino, Gabriele Fiocco, Mauro Grova, Laura Guida, Angela Alibrandi, Ambrogio Orlando, Walter Fries, the “Sicilian Network for Inflammatory Bowel Disease (SN‐IBD)”
Publikováno v:
JGH Open, Vol 5, Iss 3, Pp 364-370 (2021)
Abstract Background and Aim Ustekinumab is approved in Europe for the treatment of moderate to severe Crohn's disease (CD). Italian real‐life data are scarce, so the aim of this study was to assess the effectiveness and safety of ustekinumab in an
Externí odkaz:
https://doaj.org/article/e3341f171c794bada8cee9757434e364
Publikováno v:
Surfaces and Interfaces
Surfaces and Interfaces, 2022, Surfaces and Interfaces, 33, pp.102272. ⟨10.1016/j.surfin.2022.102272⟩
Surfaces and Interfaces, 2022, Surfaces and Interfaces, 33, pp.102272. ⟨10.1016/j.surfin.2022.102272⟩
International audience; Properties of Al/TiB2 heterophase interfaces are investigated by means of atomic-scalecalculations. Focusing on practically important (111)Al // (0001)TiB2 basal interfaces, ourstudy allows to clarify various ambiguities prese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1e943f90a7eb5b1a71dbeadb294341a
https://hal.univ-lille.fr/hal-03807701/document
https://hal.univ-lille.fr/hal-03807701/document
Publikováno v:
Journal of Crohn's and Colitis. 17:i857-i858
Background Many observational studies on the use of vedolizumab (VDZ) in patients with Crohn’s disease (CD) and ulcerative colitis (UC) have been published in the last few years. We aimed to comprehensively summarize its effectiveness and safety by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12b337b44f006a876896d29c478d4487
https://doi.org/10.1093/ecco-jcc/jjac190.0857
https://doi.org/10.1093/ecco-jcc/jjac190.0857
Autor:
Fabio S, Macaluso, Ambrogio, Orlando
Publikováno v:
The New England journal of medicine. 386(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7f63c4d41ea9b5432268f26896edf391
https://pubmed.ncbi.nlm.nih.gov/35020995
https://pubmed.ncbi.nlm.nih.gov/35020995
Autor:
S. Peuget, J.M. Delaye, F. Lodesani, A. Le Gac, S. Macaluso, Frédéric Angeli, Thibault Charpentier
Publikováno v:
Journal of Non-Crystalline Solids
Journal of Non-Crystalline Solids, Elsevier, 2021, 567, pp.120936. ⟨10.1016/j.jnoncrysol.2021.120936⟩
Journal of Non-Crystalline Solids, 2020, 567, pp.120936. ⟨10.1016/j.jnoncrysol.2021.120936⟩
Journal of Non-Crystalline Solids, Elsevier, 2021, 567, pp.120936. ⟨10.1016/j.jnoncrysol.2021.120936⟩
Journal of Non-Crystalline Solids, 2020, 567, pp.120936. ⟨10.1016/j.jnoncrysol.2021.120936⟩
International audience; A set of alumino-silicate glasses with SiO2-Al2O3-Na2O-CaO compositions was investigated using Raman and NMR spectroscopy techniques and by classical molecular dynamics, in order to study the structural modifications which occ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7c83d06a722730675dc1dda1547871e
https://hal-cea.archives-ouvertes.fr/cea-03234322
https://hal-cea.archives-ouvertes.fr/cea-03234322
P347 Sarcopenia is a poor prognostic factor for endoscopic outcomes in patients with Crohn’s disease
Autor:
M Grova, F Crispino, M Maida, A Vitello, L Tesè, G Rizzuto, A Casà, S Renna, F S Macaluso, A Orlando
Publikováno v:
Journal of Crohn's and Colitis. 16:i360-i361
Background Sarcopenia is defined as depletion in lean muscle mass with a loss of muscle strength and has been associated with increased morbidity and mortality in chronic diseases. Despite the risks and potential consequences of low lean muscle mass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::769efc89ead21fd95fb80041100ec09e
https://doi.org/10.1093/ecco-jcc/jjab232.474
https://doi.org/10.1093/ecco-jcc/jjab232.474
Autor:
F S Macaluso, M Grova, M Saladino, M G Demarzo, A C Privitera, E Giangreco, S Garufi, S Renna, A Casà, M Ventimiglia, M Cappello, W Fries, A Orlando
Publikováno v:
Journal of Crohn's and Colitis. 16:i359-i360
Background There is no head-to-head trial comparing ustekinumab (UST) and vedolizumab (VDZ) in Crohn’s disease (CD). Recently, real-world studies evaluated the two biologics in patients refractory to anti-TNF therapy, i.e. as second-line agents. Co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1c2ed974351ecf266b1045011b33f5b
https://doi.org/10.1093/ecco-jcc/jjab232.472
https://doi.org/10.1093/ecco-jcc/jjab232.472
Publikováno v:
Journal of Crohn's and Colitis. 16:i540-i541
Background Vaccination is the most effective method to prevent and control the SARS-CoV-2 infection. Recommendations consider patients with inflammatory bowel disease (IBD), Crohn’s disease (CD) and ulcerative colitis (UC), a high-priority populati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::524867a886cb1b94a0e2569240c1ee0f
https://doi.org/10.1093/ecco-jcc/jjab232.736
https://doi.org/10.1093/ecco-jcc/jjab232.736
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Loria, Francesco1 (AUTHOR), Mone, Pasquale2,3,4 (AUTHOR), Rispoli, Antonella5 (AUTHOR), Di Fonzo, Rosanna1 (AUTHOR), Masarone, Daniele6 (AUTHOR), Mancusi, Costantino7 (AUTHOR), Correale, Michele8 (AUTHOR), Vitullo, Antonio8 (AUTHOR), Granatiero, Michele8 (AUTHOR), Mazzeo, Pietro9 (AUTHOR), Mercurio, Valentina10 (AUTHOR), Fiore, Francesco10 (AUTHOR), Di Sarro, Elena10 (AUTHOR), Falco, Luigi6 (AUTHOR), Izzo, Carmine1 (AUTHOR), Campanile, Alfonso5 (AUTHOR), Virtuoso, Nicola5 (AUTHOR), Stabile, Eugenio9 (AUTHOR), Bonanno, Salvatore11 (AUTHOR), Dattilo, Giuseppe11 (AUTHOR)
Publikováno v:
Cardiovascular Diabetology. 11/22/2024, Vol. 23 Issue 1, p1-14. 14p.